124 related articles for article (PubMed ID: 3881650)
1. Suppression of basal, but not of glucose-stimulated insulin secretion by human insulin in healthy and obese hyperinsulinemic subjects.
Bratusch-Marrain PR; Waldhäusl WK
Metabolism; 1985 Feb; 34(2):188-93. PubMed ID: 3881650
[TBL] [Abstract][Full Text] [Related]
2. Hyperinsulinemia in the physiologic range is not superior to short-term fasting in suppressing insulin secretion in obese men.
Pincelli AI; Brunani A; Caumo A; Scacchi M; Pasqualinotto L; Tibaldi A; Dubini A; Bonadonna S; Cavagnini F
Metabolism; 2001 Jan; 50(1):107-11. PubMed ID: 11172483
[TBL] [Abstract][Full Text] [Related]
3. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
Henry RR; Brechtel G; Griver K
J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
[TBL] [Abstract][Full Text] [Related]
4. Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose.
Goodner CJ; Conway MJ; Werbach JH
J Clin Invest; 1969 Oct; 48(10):1878-87. PubMed ID: 5822593
[TBL] [Abstract][Full Text] [Related]
5. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM.
Ratheiser K; Reitgruber W; Komjati M; Bratusch-Marrain P; Vierhapper H; Waldhäusl WK
Acta Diabetol Lat; 1990; 27(3):197-213. PubMed ID: 2075783
[TBL] [Abstract][Full Text] [Related]
7. Use of a variable insulin infusion to assess insulin action in obesity: defects in both the kinetics and amplitude of response.
Doeden B; Rizza R
J Clin Endocrinol Metab; 1987 May; 64(5):902-8. PubMed ID: 3549759
[TBL] [Abstract][Full Text] [Related]
8. Failure of insulin infusion during euglycemia to influence endogenous basal insulin secretion.
Kraegen EW; Lazarus L; Campbell LV
Metabolism; 1983 Jun; 32(6):622-7. PubMed ID: 6341777
[TBL] [Abstract][Full Text] [Related]
9. Human aging is associated with altered TNF-alpha production during hyperglycemia and hyperinsulinemia.
Kirwan JP; Krishnan RK; Weaver JA; Del Aguila LF; Evans WJ
Am J Physiol Endocrinol Metab; 2001 Dec; 281(6):E1137-43. PubMed ID: 11701426
[TBL] [Abstract][Full Text] [Related]
10. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of gastric inhibitory polypeptide on hepatic and extrahepatic insulin action.
Service FJ; Heiling VJ; Go VL; Rizza RA
J Clin Endocrinol Metab; 1990 May; 70(5):1398-402. PubMed ID: 2110575
[TBL] [Abstract][Full Text] [Related]
12. Effect of intravenously infused porcine GIP on serum insulin in obese and lean subjects studied with the hyperglycemic clamp technique.
Amland PF; Jorde R; Burhol PG; Giercksky KE
Scand J Gastroenterol; 1985 Apr; 20(3):309-14. PubMed ID: 3890138
[TBL] [Abstract][Full Text] [Related]
13. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH
J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
[TBL] [Abstract][Full Text] [Related]
14. Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects.
Waldhäusl WK; Gasić S; Bratusch-Marrain P; Korn A; Nowotny P
Am J Physiol; 1982 Dec; 243(6):E476-82. PubMed ID: 6756164
[TBL] [Abstract][Full Text] [Related]
15. Effects of prior high-intensity exercise on glucose metabolism in normal and insulin-resistant men.
Devlin JT; Horton ES
Diabetes; 1985 Oct; 34(10):973-9. PubMed ID: 3930321
[TBL] [Abstract][Full Text] [Related]
16. Quantitative study of insulin secretion and clearance in normal and obese subjects.
Polonsky KS; Given BD; Hirsch L; Shapiro ET; Tillil H; Beebe C; Galloway JA; Frank BH; Karrison T; Van Cauter E
J Clin Invest; 1988 Feb; 81(2):435-41. PubMed ID: 3276729
[TBL] [Abstract][Full Text] [Related]
17. Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene.
Surmely JF; Guenat E; Philippe J; Dussoix P; Schneiter P; Temler E; Vaxillaire M; Froguel P; Jéquier E; Tappy L
Diabetes; 1998 Sep; 47(9):1459-63. PubMed ID: 9726235
[TBL] [Abstract][Full Text] [Related]
18. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.
Bolli G; De Feo P; Perriello G; De Cosmo S; Compagnucci P; Santeusanio F; Brunetti P; Unger RH
J Clin Invest; 1984 Apr; 73(4):917-22. PubMed ID: 6368593
[TBL] [Abstract][Full Text] [Related]
20. Insulin and glucagon secretion are suppressed equally during both hyper- and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus.
Murayama Y; Kawai K; Watanabe Y; Yoshikawa H; Yamashita K
J Clin Endocrinol Metab; 1989 May; 68(5):925-31. PubMed ID: 2654170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
